Shanlee Davis
Pediatric Emergency Medicine · Aurora, CONPI 1710203229
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,900 of the $4,771 with a category attached, or 81.7%. Antares Pharma, Inc. accounts for 97.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $3,257 and has fallen 57.0% since, to $1,400 in 2025. Among pediatric emergency medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 8 payments — averaging $596.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Antares Pharma, Inc.$5K
- Ascendis Pharma Endocrinology Inc$114
Across 151 payments — averaging $6644.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ascendis Pharma Endocrinology Inc$617K
- Neurocrine Biosciences, Inc.$222K
- Biomarin Pharmaceutical Inc.$130K
- Amgen$34K
What the payments were for
- Consulting fees$3,90082%
- Travel & lodging$47510%
- Food & beverage$3958%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Antares Pharma, Inc. | 6 | $4,657 |
| Ascendis Pharma Endocrinology Inc | 2 | $114 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYOSTED$4,540
How this compares
$4,771 in reported general payments places this provider in the 95th percentile of 45 pediatric emergency medicine providers in Colorado.
See all pediatric emergency medicine providers in Colorado →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XyostedTestosterone Enanthate | 14 | $8,751 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $1,019 |
| Testosterone Cypionate | 14 | $675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Antares Pharma, Inc.Xyosted | $4,657 | $8,75114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 45 pediatric emergency medicine providers in Colorado.
Other pediatric emergency medicine in Aurora
- Emily GreenwaldAurora$6K
- Nidhya NavanandanAurora$3K
- Bryan WilsonAurora$897
- Katherine KrueckAurora$786
- Melisa TanverdiAurora$580
- Arleta RewersAurora$551
- Jill KramerAurora$498
- Jessica GrahamAurora$380
- Hiu Fung LamAurora$283
- Leah WilliamsAurora$273
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.